<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03559634</url>
  </required_header>
  <id_info>
    <org_study_id>201805104</org_study_id>
    <nct_id>NCT03559634</nct_id>
  </id_info>
  <brief_title>Contraception Initiation Feasibility in the Pediatric ED</brief_title>
  <official_title>Feasibility Trial of Hormonal Contraceptive Initiation Program in the Pediatric Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many female adolescents using the pediatric emergency department (ED) are at higher risk for
      unintended pregnancy. This is a significant public health issue and hormonal contraception is
      the mainstay of prevention. Many barriers to hormonal contraception exist and other studies
      have demonstrated that referral from the ED for hormonal contraception leads to poor follow
      up.

      This study will be a pilot study to assess the feasibility of initiating hormonal
      contraception in the pediatric ED.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will assess the feasibility of initiating hormonal contraception in the pediatric
      ED. Currently, all 15-21-year-old patients receiving care in our ED are asked to complete an
      adolescent heath questionnaire to identify risk-factors for sexually transmitted infections
      (STIs). Sexually active female patients who indicate on this questionnaire they are not
      currently using hormonal contraception will be eligible for participation in this study.

      Potential participants will be screened using the EMR and eligible patients will be
      approached. Consent will be obtained from adults directly and from a parent or guardian for
      minors that have one present. For minors that present without a parent or guardian, assent
      only with be obtained from the minor. Participants will be randomized into two groups, an
      intervention group and a control group. Participants in both groups will be given tablet
      computer and, through a software application on the tablet, answer questions electronically
      about their background, medical history, and contraceptive preferences. They will then be
      shown a video that provides an overview of hormonal contraceptive options. Depending on the
      participants medical history and contraceptive preferences, they may be offered more in-depth
      educational videos about specific types of hormonal contraception for which they are eligible
      (e.g. pill, transdermal patch, intravaginal ring, injection, and implant).

      Once they have completed watching the videos, participants in the intervention group will
      have the option of initiating one of the offered forms of birth control during the ED visit.
      They will only be offered medications considered low risk and for which they do not have any
      medical contraindications. Urine pregnancy testing will be done before any method is given.
      They will be able to start any contraceptive method from among those offered after their
      screening. Participants in the control group will be offered outpatient referral to initiate
      contraception, the current standard of care in our ED. All patients in both arms of the study
      will be given referral/follow up options for further contraceptive care.

      All participants in this study will then be followed up at 1, 3, 6, and 12 months to
      determine continuation of contraception practices, follow up practices, satisfaction, and
      pregnancy rates.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    COVID
  </why_stopped>
  <start_date type="Actual">May 20, 2019</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Feasibility trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Initiation of contraception in the ED using the electronic application</measure>
    <time_frame>12 months</time_frame>
    <description>The proportion of enrolled patients that initiate contraception when offered same-day (intervention arm) compared to those that initiate contraception at follow up (the control arm) at 3 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delivery process related outcomes #1</measure>
    <time_frame>At initial encounter.</time_frame>
    <description>Total length of time of the intervention beginning after consent and ending with provision of contraception, contraceptive script, or declining initiation of contraception.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delivery process related outcomes #2</measure>
    <time_frame>At initial encounter.</time_frame>
    <description>Subject length of stay defined by arrival time to disposition (admit or discharge) from ED.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delivery process related outcomes #3</measure>
    <time_frame>At initial encounter and at follow up at 3, 6, and 12 months.</time_frame>
    <description>Patient experience and satisfaction survey both directly after program and at follow up at 3, 6, and 12 months. Likert 5 point scale will be used with the following rating options strongly agree, agree, no opinion, disagree, or strongly disagree. Data will be stored in original language and in a numerical scale, with a range of 1 to 5 with 5 for the question being better experience/satisfaction. Following completion of enrollment, all data will be aggregated and analyzed to determine mean and standard deviation of all questions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delivery process related outcomes #4</measure>
    <time_frame>At initial encounter.</time_frame>
    <description>Providers (doctors and nurses) experience and satisfaction survey for initial visit in ED. Likert 5 point scale will be used with the following rating options strongly agree, agree, no opinion, disagree, or strongly disagree. Data will be stored in original language and in a numerical scale, with a range of 1 to 5 with 5 for the question being better experience/satisfaction. Following completion of enrollment, all data will be aggregated and analyzed to determine mean and standard deviation of all questions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contraceptive continuation</measure>
    <time_frame>At 3,6, and 12 months.</time_frame>
    <description>Percentage of participants that are using hormonal contraception in the intervention group as compared to the control group at 1, 3, 6 and 12 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rates</measure>
    <time_frame>12 months.</time_frame>
    <description>The number of participants that become pregnant within 12 months in the intervention group verses the control group.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Contraception</condition>
  <condition>Contraception Behavior</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using an electronic application, participants answer survey questions about their sexual history, medical history, and contraceptive preferences. They will watch a video that overviews the types of hormonal contraception. Then, based on survey answers, they will be able to watch more in-depth educational videos on methods that they qualify for. Participants will only be offered methods that are considered low risk and without any contraindication based upon responses to survey screening. This may include, contraceptive implant, medroxyprogesterone acetate injection, microgestin pills, xulane patch, or intravaginal ring. Participants will then be given the opportunity to initiate contraception in the ED. All participants will be referred for follow up outpatient health services. Subjects who have medical contraindications to certain contraceptive medications will be given a standardized handout that explains why they were not eligible for the medication(s) while in the ED.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Using an electronic application, participants answer survey questions about their background, sexual history, medical history, and contraceptive preferences. They will watch a video that overviews the types of hormonal contraception with brief pros and cons of each method. Then, based on participants medical history and contraceptive preferences they will be able to watch more in-depth counseling and educational videos on contraceptive methods that they qualify for. After these videos they will be given information on where they will be able to follow up to receive these contraceptive methods if they wish to start a method. Subjects who have medical contraindications to certain hormonal contraceptive medications will be given a standardized handout that explains why they were not eligible for the medication(s), should this come up in future discussions with their providers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Intervention Group</intervention_name>
    <description>The electronic application will collect screening health information and contraceptive preferences about the participant. Then, using branch logic, decide which contraceptive options the participant would qualify for based on health history answers. Contraceptive choices being offered include the contraceptive implant, injection, pill, patch, or ring. They will then be able to watch videos about methods they are eligible for. The participant can then decide if they would like to start a medication they qualify for in the ED.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Group</intervention_name>
    <description>The electronic application will collect screening health information and contraceptive preferences about the participant. Then, using branch logic, decide which contraceptive options the participant would qualify for based on health history answers. This includes the contraceptive implant, injection, pill, patch, or ring. They will then be able to watch videos about methods they are eligible for. Participants will then be given follow up information on outpatient locations where they can receive these contraceptive methods.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients, 15-21 years old that present to the SLCH pediatric ED

          -  Report history of vaginal sex on the ED routine screening questionnaire

          -  Not currently using hormonal contraception

        Exclusion Criteria:

          -  Pregnant

          -  Currently using hormonal contraception

          -  Foster care

          -  Non-English speaking

          -  Chief complaint of psychiatric concern, physical abuse or sexual abuse

          -  Triage acuity level 1 or 2 as they are likely to be too ill to participate

          -  Those with history of stroke, venous thromboembolism, actively being treated for
             cancer, or who have an organ transplant

          -  Too ill to participate as determined by the pediatric ED health care provider
             (attending physician or advanced practice nurse)

          -  Already participated in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Must be a biological female that identifies as a female.</gender_description>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Washington Univeristy at St Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Centers for Disease Control and Prevention. Reproductive Health: Teen Pregnancy. http://www.cdc.gov/teepregnancy/about/index.htm. Accessed Sept 2016.</citation>
  </reference>
  <reference>
    <citation>American College of Obstetricians and Gynecologists. Guidelines for adolescent health care. 2011; http://www.acog.org/About-ACOG/ACOG-Departments/Adolescent-Health-Care. Accessed Dec 2016.</citation>
  </reference>
  <reference>
    <citation>American Congress of Obstetricians and Gynecologists. Statement on Teen Pregnancy and Contraception. 2015; http://www.acog.org/About-ACOG/News-Room/Statements/2015/ACOG-Statement-on-Teen-Pregnancy-and-Contraception. Accessed Dec 2016.</citation>
  </reference>
  <reference>
    <citation>Committee on Adolescence. Contraception for adolescents. Pediatrics. 2014 Oct;134(4):e1244-56. doi: 10.1542/peds.2014-2299. Review.</citation>
    <PMID>25266430</PMID>
  </reference>
  <reference>
    <citation>Healthy People 2020. Family Planning, Adolescent Health. 2014; https://www.healthypeople.gov/2020, 2017.</citation>
  </reference>
  <reference>
    <citation>Society for Adolescent Health and Medicine, Burke PJ, Coles MS, Di Meglio G, Gibson EJ, Handschin SM, Lau M, Marcell AV, Tebb KP, Urbach K. Sexual and reproductive health care: a position paper of the Society for Adolescent Health and Medicine. J Adolesc Health. 2014 Apr;54(4):491-6. doi: 10.1016/j.jadohealth.2014.01.010.</citation>
    <PMID>24656535</PMID>
  </reference>
  <reference>
    <citation>Chernick LS, Schnall R, Higgins T, Stockwell MS, Casta√±o PM, Santelli J, Dayan PS. Barriers to and enablers of contraceptive use among adolescent females and their interest in an emergency department based intervention. Contraception. 2015 Mar;91(3):217-25. doi: 10.1016/j.contraception.2014.12.003. Epub 2014 Dec 12.</citation>
    <PMID>25499588</PMID>
  </reference>
  <reference>
    <citation>Chernick LS, Westhoff C, Ray M, Garcia M, Garth J, Santelli J, Dayan PS. Enhancing referral of sexually active adolescent females from the emergency department to family planning. J Womens Health (Larchmt). 2015 Apr;24(4):324-8. doi: 10.1089/jwh.2014.4994.</citation>
    <PMID>25860108</PMID>
  </reference>
  <reference>
    <citation>Ahmad FA, Jeffe DB, Plax K, Collins KK, Schechtman KB, Doerhoff DE, Garbutt J, Jaffe DM. Computerized self-interviews improve Chlamydia and gonorrhea testing among youth in the emergency department. Ann Emerg Med. 2014 Oct;64(4):376-84. doi: 10.1016/j.annemergmed.2014.01.031. Epub 2014 Mar 6.</citation>
    <PMID>24612901</PMID>
  </reference>
  <reference>
    <citation>Ahmad FA, Jeffe DB, Plax K, Schechtman KB, Doerhoff DE, Garbutt JM, Jaffe DM. Characteristics of youth agreeing to electronic sexually transmitted infection risk assessment in the emergency department. Emerg Med J. 2018 Jan;35(1):46-51. doi: 10.1136/emermed-2016-206199. Epub 2017 Aug 11.</citation>
    <PMID>28801483</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 22, 2018</study_first_submitted>
  <study_first_submitted_qc>June 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2018</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

